TG Therapeutics SG&A Expense (TTM) Insights

TG Therapeutics Inc (TGTX)

18.31 +0.16 (+0.88%) USD | NASDAQ | Jul 02, 16:00

18.31 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1997. Upgrade now.

Date	Value
March 31, 2024	129.22M
December 31, 2023	122.70M
September 30, 2023	114.06M
June 30, 2023	95.54M
March 31, 2023	77.46M
December 31, 2022	70.00M
September 30, 2022	79.91M
June 30, 2022	100.56M
March 31, 2022	121.94M
December 31, 2021	128.09M
September 30, 2021	139.54M
June 30, 2021	139.93M
March 31, 2021	120.35M
December 31, 2020	107.85M
September 30, 2020	71.05M
June 30, 2020	38.66M
March 31, 2020	26.95M
December 31, 2019	15.03M
September 30, 2019	9.884M
June 30, 2019	7.938M
March 31, 2019	10.90M
December 31, 2018	15.16M
September 30, 2018	18.32M
June 30, 2018	21.83M
March 31, 2018	17.90M

Date	Value
December 31, 2017	16.33M
September 30, 2017	13.04M
June 30, 2017	11.73M
March 31, 2017	12.50M
December 31, 2016	9.889M
September 30, 2016	10.53M
June 30, 2016	9.654M
March 31, 2016	13.01M
December 31, 2015	15.63M
September 30, 2015	16.82M
June 30, 2015	18.32M
March 31, 2015	17.58M
December 31, 2014	15.79M
September 30, 2014	13.63M
June 30, 2014	11.22M
March 31, 2014	7.709M
December 31, 2013	6.658M
September 30, 2013	6.723M
June 30, 2013	6.500M
March 31, 2013	6.320M
December 31, 2012	4.782M
September 30, 2012	3.797M
June 30, 2012	2.658M
March 31, 2012	1.199M
December 31, 2011	1.753M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

9.884M

Minimum

Sep 2019

139.93M

Maximum

Jun 2021

89.93M

Average

100.56M

Median

Jun 2022

SG&A Expense (TTM) Benchmarks